Santoro T J, Malek T R, Rosenberg Y J, Morse H C, Steinberg A D
Arthritis and Rheumatism Branch, National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases, Bethesda, Maryland 20205.
J Mol Cell Immunol. 1984;1(6):347-56.
T cell growth is principally regulated by the lymphokine interleukin 2 (IL 2). Following induction of IL 2 receptors, immunologically normal cells proliferate and will continue to do so until the level of IL2 becomes limiting. Spleen cells from autoimmune-prone mice and peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE), however, are severely deficient in their capacity to both produce and respond to IL 2 following a challenge with mitogenic lectins. These observations have suggested the possibility that IL 2 may not function as a T cell growth factor in the autoimmune milieu. In order to determine the requirements for T lymphocyte proliferation in autoimmunity, MRL-lpr/lpr mice were studied. Spleen cells from this murine model of lupus exhibit profound defects in IL 2 activity in vitro. Yet, paradoxically, massive expansion of the T cell pool occurs in vivo. While spleen cells from such mice were, indeed, unable to produce IL 2 or to proliferate when stimulated with concanavalin A (Con A), the combination of Con A plus the comitogen phorbol myristate acetate (PMA) engendered substantial IL 2 production and normal cellular proliferation. Since numerous lymphokines are produced when cells are cultured with Con A + PMA, it remained to be shown that IL 2 was, in fact, the responsible growth factor. We found that culturing lpr spleen cells with an anti-IL 2 receptor antibody abrogated the mitogenicity of Con A + PMA; that on stimulation with Con A + PMA, MRL-lpr/lpr T cells expressed IL 2 receptors, and that addition of recombinant IL 2 to the receptor positive population resulted in marked proliferation. Furthermore, by two-color flow cytometric analysis it was demonstrated that T cells which bear the phenotype of those which undergo clonal expansion in the lpr were capable of expressing IL 2 receptors. Thus, IL 2 can be utilized as a growth factor, in vitro, by autoimmune as well as normal T cells. The etiology of the Con A unresponsiveness of MRL-lpr/lpr cells remained to be clarified. We observed that, in contrast to the refractoriness of fresh cells, lymph node cells which had been cultured for several days in the absence of antigenic stimulation were capable of expressing IL 2 receptors and of proliferating on exposure to Con A. Using flow cytometry it was found that selective expansion of a subset of phenotypically "normal" lymphocytes had not occurred.(ABSTRACT TRUNCATED AT 400 WORDS)
T细胞的生长主要受淋巴因子白细胞介素2(IL-2)的调节。在诱导IL-2受体后,免疫功能正常的细胞会增殖,并会持续增殖,直到IL-2水平变得有限。然而,来自自身免疫易感性小鼠的脾细胞和系统性红斑狼疮(SLE)患者的外周血单个核细胞,在受到促有丝分裂凝集素刺激后,产生和响应IL-2的能力严重不足。这些观察结果提示了一种可能性,即IL-2在自身免疫环境中可能无法作为T细胞生长因子发挥作用。为了确定自身免疫中T淋巴细胞增殖的条件,对MRL-lpr/lpr小鼠进行了研究。来自这种狼疮小鼠模型的脾细胞在体外表现出IL-2活性的严重缺陷。然而,矛盾的是,T细胞库在体内却大量扩增。虽然来自此类小鼠的脾细胞在用伴刀豆球蛋白A(Con A)刺激时确实无法产生IL-2或增殖,但Con A与共刺激剂佛波酯肉豆蔻酸酯(PMA)的组合可产生大量IL-2并使细胞正常增殖。由于当细胞用Con A + PMA培养时会产生多种淋巴因子,因此仍需证明IL-2实际上就是起作用的生长因子。我们发现,用抗IL-2受体抗体培养lpr脾细胞可消除Con A + PMA的促有丝分裂活性;在用Con A + PMA刺激时,MRL-lpr/lpr T细胞表达IL-2受体,并且向受体阳性群体中添加重组IL-2会导致明显的增殖。此外,通过双色流式细胞术分析表明,具有在lpr中经历克隆扩增的细胞表型的T细胞能够表达IL-2受体。因此,IL-2在体外可被自身免疫性T细胞以及正常T细胞用作生长因子。MRL-lpr/lpr细胞对Con A无反应的病因仍有待阐明。我们观察到,与新鲜细胞的难治性不同,在无抗原刺激的情况下培养数天的淋巴结细胞能够表达IL-2受体,并在接触Con A时增殖。使用流式细胞术发现,并未发生表型“正常”的淋巴细胞亚群的选择性扩增。(摘要截短至400字)